Efficacy and Safety of Abatacept in Lupus Nephritis: A Twelve‐Month, Randomized, Double‐Blind Study-Reference-Cited by-同舟云学术

Efficacy and Safety of Abatacept in Lupus Nephritis: A Twelve‐Month, Randomized, Double‐Blind Study

Published:2014-01-27 Issue:2 Volume:66 Page:379-389
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Furie Richard¹,Nicholls Kathy²,Cheng Tien‐Tsai³,Houssiau Frederic⁴,Burgos‐Vargas Ruben⁵,Chen Shun‐Le⁶,Hillson Jan L.⁷,Meadows‐Shropshire Stephanie⁷,Kinaszczuk Michael⁷,Merrill Joan T.⁸

Affiliation:

1. North Shore–LIJ Health SystemGreat NeckNew York

2. Royal Melbourne Hospital and University of MelbourneParkville, VictoriaAustralia

3. Chang Gung Memorial Hospital–Kaohsiung Medical Center and Chang Gung UniversityKaohsiungTaiwan

4. Cliniques Universitaires Saint‐Luc, Université Catholique de LouvainBrusselsBelgium

5. Hospital General de México and Universidad Nacional Autonoma de MéxicoMexico CityMexico

6. Shanghai Jiao Tong University School of MedicineShanghaiChina

7. Bristol‐Myers SquibbPrincetonNew Jersey

8. Oklahoma Medical Research FoundationOklahoma City

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.38260

Reference35 articles.

1. T Cells and B Cells in Lupus Nephritis

2. Orencia (abatacept) prescribing information. Princeton (NJ): Bristol‐Myers Squibb;2013. URL:http://packageinserts.bms.com/pi/pi_orencia.pdf.

3. Abatacept binds to the Fc receptor CD64 but does not mediate complement‐dependent cytotoxicity or antibody‐dependent cellular cytotoxicity;Davis PM;J Rheumatol,2007

4. Reduction of inflammatory biomarker response by abatacept in treatment of rheumatoid arthritis;Weisman MH;J Rheumatol,2006

5. Long‐term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways;Daikh DI;J Immunol,1997

Cited by 295 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted therapies in SLE;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Novel insights into immune checkpoints in psoriasis and atopic dermatitis: From expression and function to treatments;International Immunopharmacology;2024-09

3. Biologicals for the treatment of lupus nephritis: a Bayesian network meta-regression analysis;Frontiers in Immunology;2024-08-30

4. KDIGO 2024 Clinical Practice Guideline for the management of lupus nephritis. Translated into Russian by E.V. Zakharova;Nephrology and Dialysis;2024-08-13

5. Impact of Glucocorticoid Dose on Complete Response, Serious Infections, and Mortality During the Initial Therapy of Lupus Nephritis: A Systematic Review and Meta‐Analysis of the Control Arms of Randomized Controlled Trials;Arthritis & Rheumatology;2024-06-28